Joseph C. Hamley

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Journal: Blood
Published: July 21, 2025

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Journal: Blood
Published: July 21, 2025

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

Journal: Blood
Published: June 17, 2025

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

Journal: Blood
Published: June 17, 2025

Mapping chromatin structure at base-pair resolution unveils a unified model of cis-regulatory element interactions.

Mapping chromatin structure at base-pair resolution unveils a unified model of cis-regulatory element interactions.

Journal: Cell
Published: December 10, 2024

Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A.

Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A.

Journal: Nature genetics
Published: August 16, 2023

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.

Journal: Nature communications
Published: December 08, 2022

Determining chromatin architecture with Micro Capture-C.

Determining chromatin architecture with Micro Capture-C.

Journal: Nature protocols
Published: April 30, 2022

Maternal immune activation downregulates schizophrenia genes in the foetal mouse brain.

Maternal immune activation downregulates schizophrenia genes in the foetal mouse brain.

Journal: Brain communications
Published: March 25, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026